Test Code: 8268

Methodology: Immunofluorescent Assay (IFA)

Clinical Significance: Antinuclear antibodies are associated with rheumatic diseases including Systemic Lupus Erythematous (SLE), mixed connective tissue disease, Sjogren's syndrome, scleroderma, polymyositis, CREST syndrome, and neurologic SLE.

Includes: The ANA Screen, IFA, with Reflex Titer/Pattern

If ANA Screen, IFA is positive, then ANA Titer and Pattern will be performed at an additional charge (CPT code(s): 86039).

Test Code: 5704

Includes: Complement Component C3C; Complement Component C4C

Methodology: Immunoturbidimetric

Clinical Significance: Decreased concentrations of both C3 and C4 suggest activation of the classical pathway, whereas decreased concentration of just C3 suggests activation of the alternative pathway. Both complement factors may be used to monitor activity of patients with systemic lupus erythematosus (SLE) and immune complex-induced vasculitis.

Test Code: 34482

Methodology: Enzyme Immunoassay (EIA)

Clinical Significance: Tacrolimus is an immunosuppressive drug discovered in 1984 by the Fujisawa Pharmaceutical Co. It has been shown to be effective for the treatment of rejection following transplantation. “contact DLO Customer Service for full clinical significance if needed”.

Alternative Name(s): Prograf; FK506

Test Code: 7260

Methodology: Immunoassay (IA)

Clinical Significance: Measurement of thyroglobulin antibodies and thyroid peroxidase antibodies is useful in the diagnosis and management of a variety of thyroid disorders including autoimmune thyroiditis, Hashimoto's Disease, Graves Disease and certain types of goiter.

Alternative Name(s): Not applicable

Test Code: 5081

Methodology: Immunoassay (IA)

Clinical Significance: Assists in the diagnosis of thyroid diseases such as endemic goiter, Graves Disease, autoimmune thyroiditis, Addison's Disease, insulin-dependent diabetes mellitus, Hashimoto's Disease and polyendocrine auto-immunopathies.

Alternative Name(s): Anti-TPO, Anti-Thyroid Microsomal Antibody, TPO

Test Code: 267

Methodology: Immunoassay (IA)

Clinical Significance: Measurement of thyroglobulin antibodies is useful in the diagnosis and management of a variety of thyroid disorders including Hashimoto's thyroiditis, Graves' disease and certain types of goiter.

Alternative Name(s): Thyroglobulin Antibody; Anti-TG; Anti-thryglobulin

Test Code: 11173

Methodology: Immunoassay (IA)

Clinical Significance: A synthetic circular peptide containing citrulline called CCP IgG (cyclic citrullinated peptide) has been found to be better at discriminating Rheumatoid Arthritis patients from other patients than either the perinuclear autoantibody test or the test for rheumatoid factor. Approximately 70% of patients with Rheumatoid Arthritis are positive for Anti-CCP IgG, while only about 2% of random blood donors and disease controls subjects are positive.

Test Code:
RPR (Diagnosis) w/ Reflex to Titer and Confirmatory Testing: 36126
RPR (Montior) w/ Reflex to Titer: 799
RPR, Premarital w/ Relfex to Titer: 4120

Methodology: Flooculation

Test Code: 94462

Includes: IgE allergy testing for: Macadamia Nut (RF345), Pecan Nut (F201), Brazil Nut (F18), Walnut (F256), Cashew Nut (F202), Pistachio (F203), Hazelnut (F17), Almond (F20), Peanut (F13)

Methodology: Immunoassay